Article
Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone.
Hematological oncology - 1 Feb 2018
Partouche Nicolas, Conejero Carole, Barathon Quentin, Moroch Julien, Tulliez Michel, Cordonnier Catherine, Giraudier Stephane
Abstract excerpt
Myeloproliferative neoplasms are characterized by transduction pathway recognized as mutually exclusive molecular abnormalities such as BCR-ABL translocation, JAK2V617F or JAK2 exon 12 mutations, MPL w515, and CALR mutations. However, in some rare cases, associations of such mutations are found in 1 patient. This can be related to 2 pathologies (at least 2 different clones harboring 2 mutations) or associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
